Akoya Biosciences, Inc. (AKYA)
NASDAQ: AKYA · IEX Real-Time Price · USD
2.180
-0.030 (-1.36%)
At close: Jul 2, 2024, 4:00 PM
2.250
+0.070 (3.21%)
After-hours: Jul 2, 2024, 5:01 PM EDT
Akoya Biosciences Stock Forecast
Stock Price Forecast
The 7 analysts with 12-month price forecasts for Akoya Biosciences stock have an average target of 7.21, with a low estimate of 4.00 and a high estimate of 10. The average target predicts an increase of 230.73% from the current stock price of 2.18.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 3, 2024.
Analyst Ratings
The average analyst rating for AKYA stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 3 | 3 | 3 |
| Buy | 3 | 4 | 4 | 4 | 4 | 4 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 7 | 7 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Maintains $8 → $4 | Buy | Maintains | $8 → $4 | +83.49% | Jun 3, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $10 → $6 | Strong Buy | Maintains | $10 → $6 | +175.23% | May 14, 2024 |
| BTIG | BTIG | Strong Buy Maintains $9 → $6 | Strong Buy | Maintains | $9 → $6 | +175.23% | May 14, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $12 → $10 | Buy | Maintains | $12 → $10 | +358.72% | Mar 6, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +358.72% | Mar 5, 2024 |
Financial Forecast
Revenue This Year
105.76M
from 96.63M
Increased by 9.45%
Revenue Next Year
127.76M
from 105.76M
Increased by 20.80%
EPS This Year
-1.07
from -1.43
EPS Next Year
-0.65
from -1.07
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 111.3M | 142.8M | 162.4M | 188.2M | 216.5M |
| Avg | 105.8M | 127.8M | 149.0M | 157.5M | 174.9M |
| Low | 97.7M | 112.7M | 120.3M | 127.0M | 134.1M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 15.2% | 35.0% | 27.1% | 26.3% | 37.5% |
| Avg | 9.4% | 20.8% | 16.6% | 5.7% | 11.1% |
| Low | 1.1% | 6.6% | -5.8% | -14.7% | -14.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.90 | -0.45 | -0.14 | -0.08 | 0.17 |
| Avg | -1.07 | -0.65 | -0.32 | -0.35 | -0.19 |
| Low | -1.16 | -0.92 | -0.64 | -0.59 | -0.53 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.